Steinbjørn Hansen
0000-0001-5651-6493
Publication & Citation Trends
Publications
138 total
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors PDF
Cited by 171
OpenAlex
Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial—FIRSTANA
Cited by 353
OpenAlex
Tumour‐associated microglia/macrophages predict poor prognosis in high‐grade gliomas and correlate with an aggressive tumour subtype PDF
Cited by 304
OpenAlex
Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I–IV in the the Danish Neuro-Oncology Registry
Cited by 291
OpenAlex
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial PDF
Cited by 1,485
OpenAlex
Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial PDF
Cited by 170
OpenAlex
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Cited by 3,274
OpenAlex
Research Topics
Glioma Diagnosis and Treatment
(45)
Prostate Cancer Treatment and Research
(29)
Prostate Cancer Diagnosis and Treatment
(23)
Brain Metastases and Treatment
(17)
Cancer Treatment and Pharmacology
(13)
Affiliations
Université Paris-Sud
Cliniques Universitaires Saint-Luc
Inserm
Universität Hamburg
University of Southern Denmark